Vitamin D3 for Life

Live Enlightened

Research libraryVitamin D3 For Life
Study design and methods

Primary relevance to vitamin D Vitamin D is a stated subject of this paper.

Vitamin D is a stated subject of this paper; the supporting source evidence is shown below.

Why this paper is included

Supporting source evidence:

The Vitamin D Receptor as a Prognostic Marker in Breast Cancer: A Cohort Study

Source: Article title. View original paper

Relevance classification does not establish study quality, causation or editorial approval.

Study design Cohort study.

Cohort study

Examines exposures and outcomes over time within a defined group.

Meta-analysis unclear · Blinding unclear / not reported · Human research reported

How this paper was classified

Automatic source-based classification; awaiting editorial verification. This is not a quality score.

The Vitamin D Receptor as a Prognostic Marker in Breast Cancer: A Cohort Study

Source: Article title.

During this period, 1116 patients were included in the study.

Source: Methods.

View supporting evidence in the original paper

What the study types mean
Systematic review
Uses explicit methods to identify, assess and summarise research on a defined question.
Scoping review
Maps the extent and characteristics of research on a topic.
Narrative review
Discusses existing research; systematic-review methods have not been established by this classification.
Review / evidence synthesis
Reviews existing research; the exact review methods need further assessment.
Randomised controlled trial
Assigns participants or groups to comparison interventions by chance.
Non-randomised intervention study
Examines an intervention without random allocation.
Cohort study
Examines exposures and outcomes over time within a defined group.
Case-control study
Compares people with an outcome against people without it, examining exposures.
Cross-sectional study
Examines a population at a particular point in time.
Observational study
Observes exposures and outcomes without assigning the exposure; the subtype is not established here.
Case report
Describes an individual case.
Case series
Describes a group of individual cases.
Secondary analysis
Analyses existing study data; this paper is not automatically another independent trial.
Laboratory study
Investigates biological processes in a laboratory setting.
Qualitative study
Examines experiences or meanings using qualitative methods.
Genetic instrumental-variable study
Uses genetic variation as an instrument to investigate relationships; this is not a randomised treatment trial.
Study protocol
Describes planned methods and is not evidence that the planned study has reported results.
Multiple reported designs
More than one design is explicitly reported; examine the supporting methods.
Study design awaiting verification
The available source does not establish a sufficiently clear study design.

Meta-analysis combines numerical results from studies. Blinding describes who was unaware of treatment allocation. Neither is a separate quality grade. Study design, vitamin D relevance and document format are independent filters.

Abstracts

The Vitamin D Receptor as a Prognostic Marker in Breast Cancer: A Cohort Study

Cohort study · Nutrients · 2024

Original publication title

The Vitamin D Receptor as a Prognostic Marker in Breast Cancer: A Cohort Study

Linnea Huss; Igis Gulz-Haake; Emma Nilsson; Helga Tryggvadottir; Linn Nilsson; Björn Nodin; Karin Jirström; Karolin Isaksson; Helena Jernström

© 2024 by the authors.

Original publication · Publisher record · CC BY 4.0

Source wording retained. Formatting, section navigation and display-title punctuation adapted for this research record.

At a glance

What does the authors’ abstract report?

Previous research has indicated an association between the presence of the vitamin D receptor (VDR) in breast cancer tissue and a favorable prognosis. This study aimed to further evaluate the prognostic potential of VDR located in the nuclear membrane or nucleus (liganded). The VDR protein levels were analyzed using immunohistochemistry in tumor samples from 878 breast cancer patients from Lund, Sweden, included in the Breast Cancer and Blood Study (BCBlood) from October 2002 to June 2012. The follow-up for breast cancer events and overall survival was recorded until 30 June 2019.

Univariable and multivariable survival analyses were conducted, both with complete case data and with missing data imputed using multiple imputation by chained equations (MICE). Tumor-specific positive nuclear membrane VDR(num) staining was associated with favorable tumor characteristics and a longer breast cancer free interval (BCFI; HR: 0.64; 95% CI: 0.44 to 0.95) and overall survival (OS; HR: 0.52; 95% CI: 0.34 to 0.78). Further analyses indicated that VDRnum status also was predictive of overall survival when investigated in relation to ER status. There were significant interactions between VDR and invasive tumor size (Pinteraction = 0.047), as well as mode of detection (Pinteraction = 0.049).

VDRnum was associated with a longer BCFI in patients with larger tumors (HR: 0.36; 95% CI: 0.14 to 0.93) or clinically detected tumors (HR: 0.28; 95% CI: 0.09 to 0.83), while no association was found for smaller tumors and screening-detected tumors. Further studies are suggested to confirm our results and to evaluate whether VDR should and could be used as a prognostic and targetable marker in breast cancer diagnostics.

Authors’ abstract

Previous research has indicated an association between the presence of the vitamin D receptor (VDR) in breast cancer tissue and a favorable prognosis. This study aimed to further evaluate the prognostic potential of VDR located in the nuclear membrane or nucleus (liganded). The VDR protein levels were analyzed using immunohistochemistry in tumor samples from 878 breast cancer patients from Lund, Sweden, included in the Breast Cancer and Blood Study (BCBlood) from October 2002 to June 2012. The follow-up for breast cancer events and overall survival was recorded until 30 June 2019.

Univariable and multivariable survival analyses were conducted, both with complete case data and with missing data imputed using multiple imputation by chained equations (MICE). Tumor-specific positive nuclear membrane VDR(num) staining was associated with favorable tumor characteristics and a longer breast cancer free interval (BCFI; HR: 0.64; 95% CI: 0.44 to 0.95) and overall survival (OS; HR: 0.52; 95% CI: 0.34 to 0.78). Further analyses indicated that VDRnum status also was predictive of overall survival when investigated in relation to ER status. There were significant interactions between VDR and invasive tumor size (Pinteraction = 0.047), as well as mode of detection (Pinteraction = 0.049).

VDRnum was associated with a longer BCFI in patients with larger tumors (HR: 0.36; 95% CI: 0.14 to 0.93) or clinically detected tumors (HR: 0.28; 95% CI: 0.09 to 0.83), while no association was found for smaller tumors and screening-detected tumors. Further studies are suggested to confirm our results and to evaluate whether VDR should and could be used as a prognostic and targetable marker in breast cancer diagnostics.

Publication and source details

Original title: The Vitamin D Receptor as a Prognostic Marker in Breast Cancer: A Cohort Study

Linnea Huss; Igis Gulz-Haake; Emma Nilsson; Helga Tryggvadottir; Linn Nilsson; Björn Nodin; Karin Jirström; Karolin Isaksson; Helena Jernström

Nutrients · 2024

* Correspondence: linnea.huss@med.lu.se (L.H.); helena.jernstrom@med.lu.se (H.J.)
†

These authors contributed equally to this work.

© 2024 by the authors.2024https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).Swedish Cancer SocietyCAN 20 0763CAN 23 2952Faculty of Medicine at Lund UniversityGorthon FoundationMrs. Berta Kamprad FoundationSouth Swedish Health Care RegionALF 40620Skåne University Hospital FundThe funders of this study include the Swedish Cancer Society (CAN 20 0763 and CAN 23 2952), the Faculty of Medicine at Lund University, the Gorthon Foundation, the Mrs. Berta Kamprad Foundation, the South Swedish Health Care Region (Region Skåne ALF 40620), and the Skåne University Hospital Fund. The funders had no role in the study design, conduct of the study, data collection and analysis, data interpretation, manuscript preparation, or the decision to submit the manuscript for publication.

Repository JATS snapshot; version as supplied

Source retrieved: 2026-11-11T04:57:40.452680+00:00

DOI: 10.3390/nu16070931 · PMC11013402